MONJUVI vs ZYNLONTA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated June 7, 2026·How we rate

Possible drug interaction. MONJUVI and ZYNLONTA are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	MONJUVI	ZYNLONTA
Rating	New	New
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	TAFASITAMAB-CXIX	LONCASTUXIMAB TESIRINE-LPYL
Manufacturer	Morphosys US Inc	Adc Therapeutics Sa
Dosage forms	Injectable	Injectable
Drug class	—	—
Boxed warning	None	None
Treats	Diffuse Large B-Cell Lymphoma	Diffuse Large B-Cell Lymphoma

monjuvi zynlonta

Rating

New

Pharmacy pays

—

Type

Active ingredient

TAFASITAMAB-CXIX

LONCASTUXIMAB TESIRINE-LPYL

Manufacturer

Morphosys US Inc

Adc Therapeutics Sa

Dosage forms

Injectable

Drug class

—

Boxed warning

None

Treats

Diffuse Large B-Cell Lymphoma

Frequently asked questions

What is the difference between Monjuvi and Zynlonta?

Monjuvi contains Tafasitamab-Cxix, while Zynlonta contains Loncastuximab Tesirine-Lpyl — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.